eFFECTOR Therapeutics Inc financial statements
eFFECTOR Therapeutics Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2023
| Revenue | USD 0 | EODHD |
| Net income | −USD 35.81M | EODHD |
| Cash and equivalents | USD 14.88M | EODHD |
| Total debt | USD 20.55M | EODHD |
eFFECTOR Therapeutics Inc financials on 6ix · eFFECTOR Therapeutics Inc on 6ix